Skip to content

News
 

2010 California Biomedical Industry Highlights

Companies: California is home to more than 2,000 companies and more than 100 universities and private non-profit research organizations that are engaged in biomedical R&D and manufacturing.

Employment: The biomedical industry is one of the most recession-resilient sectors in the state’s economy, accounting for 274,000 California jobs; if you include a multiplier effect for people employed in firms that offer goods and services that number climbs to more than 750,000.

Employment in the industry is diverse: 41 percent of employees work in businesses making medical devices, instruments and diagnostic tools; 30 percent in biopharmaceutical companies; 15 percent in academic research; 12 percent in wholesale trade; and 2 percent in laboratory services. Among the state’s high-tech industries, only the information technology sectors (computer and Internet-related services and computer and peripheral equipment industries) employ more people than the biomedical industry.

Wages: California biomedical industry employees earned a total of $20.5 billion.For the year, the average annual wage for the industry across the state was $75,000 in 2008, as it was in 2007. Within the sector, biopharmaceutical companies paid the highest average annual wage—$108,380.

Venture capital investment: In 2009, California’s biomedical companies completed 252 deals valued at $2.6 billion, down from 302 deals worth $3.5 billion in 2008 but still attracting more venture capital investment than any other sector in the state.

Product development: There are 869 new medicines in California’s R&D pipeline, with 480 (55 percent) being evaluated in clinical trials. Nearly one third (272 or 31 percent) of the products in California companies’ pipelines target cancer.

Revenues: California’s biomedical companies’ revenues for 2008 were an estimated $75.9 billion.

NIH grants: California received the greatest amount of NIH funding of any state, receiving 7,228 grants totaling $3.15 billion in 2008. California’s share of funding was approximately 40 percent more than the second largest grantee, Massachusetts, which received $2.2 billion. California received 15.1 percent of all NIH funds. For the top 10 states, NIH funding remained virtually flat from 2007 to 2008.

 


Sign up to receive the full Industry Report.

View a PDF version of the highlights

Source: California Healthcare Institute/PricewaterhouseCoopers
2010 Report on California's Biomedical Industry